Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. - Strohl WR; Ku Z; An Z; Carroll SF; Keyt BA; Strohl LM (BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2022)